Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/27/2010CN101336897B Preparation method and use of stable o-methylhydroquione
10/27/2010CN101322802B Paste for curing psoriasis and preparation thereof
10/27/2010CN101322718B Injection for reducing drug dependency and preparation thereof
10/27/2010CN101288728B Plaster for treating rheumatism, rheumatoid, a variety of hyperosteogenys
10/27/2010CN101249265B Intravenous injection employ persons hepatitis B immune globulin and method of preparing the same
10/27/2010CN101239996B Method for preparing high shearing force microcrystal lactose
10/27/2010CN101239165B Chinese herbal medicine for treating gynaecologic postpartum disease
10/27/2010CN101239128B Menstruation-regulating face-nourishing Chinese medicinal composition and preparation thereof
10/27/2010CN101239094B Active component composition used as adjuvant drug for antitumor and preparation and application thereof
10/27/2010CN101239086B Injection drug administration for treating cardio-cerebrovascular disease and preparations thereof
10/27/2010CN101229172B Solid dispersing agent of glycyrrhetinic acid 30-acylamide derivatives, preparing method and uses thereof
10/27/2010CN101209171B Pillow containing tea, carbon and Chinese herbal medicine composite granules and preparation method thereof
10/27/2010CN101181463B Chinese medicine composition for treating diabetes and method for preparing the same
10/27/2010CN101181247B Biphenyl benzyl azoles aerosol and preparation method thereof
10/27/2010CN101181232B Marseilledinun sustained-release implantation agent for curing entity tumour
10/27/2010CN101129605B Mightiness nourishing capsule
10/27/2010CN101081215B Conotoxin SO3 nanometer grain composition and method of making the same and the application thereof
10/27/2010CN101040889B Traditional Chinese medicinal prepns. for treating osteoporosis
10/27/2010CN101028521B Oral colon positioning feed preparation based on electric spinning superfine nuclear fibre and its making method
10/26/2010USRE41884 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
10/26/2010US7820788 injection comprising paclitaxel and albumin to reduce side effects; drugs such as propofol or paclitaxel; for cancer, arthritis, or restenosis
10/26/2010US7820753 core blocks formed of 2-methacryloyloxyethyl-2'-trimethylammonium ethylphosphate inner salt (MPC) and terminal blocks formed of 2-(diisopropylamino)ethyl methacrylate; ability to undergo changes, when exposed to selected stimuli, often reversibly. gelled by changing the pH ; for drug delivery systems
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820720 antifungal formulations comprising terbinafine or a pharmaceutically acceptable salt thereof, a lipid, and a surfactant; uses thereof for the treatment of skin and nail fungal infections
10/26/2010US7820651 for catheter and port systems, for preventing infections and sepsis
10/26/2010US7820643 Therapeutic treatment by administering milnacipran, a new use of existing pharmaceutical
10/26/2010US7820627 with core structure of pentaerythritol used as replacement for sugars; immunomodulators; immunogens within liposomes; tumor antigens; for use as haptens, inhibitors of bacterial-host cell adhesion; septic shock
10/26/2010US7820420 Using nitrosomonas bacteria to enhance vascular, sexual and skin health
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820211 Cosmetic material containing sweet pea extract
10/26/2010US7820205 Platinum colloid-containing aqueous solution for treating schizophrenia
10/26/2010US7820204 Drug delivery system targeting to estrogen receptor over-expressed cells
10/26/2010US7820203 Modified release dosage forms of skeletal muscle relaxants
10/26/2010US7820202 Sustained release drugs, foods, plant safening agents
10/26/2010US7820201 controlled release dosage forms and methods of designing and manufacturing dosage forms to obtain specific release profiles zero-order release profiles, escalating release profiles or decreasing release profiles. The dosage forms of the present invention can include spatial variation of API dosage forms
10/26/2010US7820200 can be used to obtain a constant concentration of the active principle in the blood, thereby enabling the demethylating effect of the hydralazine without producing the hypotensive action thereof, such that the inventive composition can be used in cancer therapy
10/26/2010US7820199 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine
10/26/2010US7820198 solid tablet comprising a blend of hydrated calcium hypochlorite with magnesium sulfate heptahydrate, calcium hypochlorite, and alkali metal phosphate scale inhibitor; for use as sanitizer in pool chemicals; even dissolution; easy recognition of chemical tablet by its unique shape
10/26/2010US7820197 Using bisphosphonic acid compound; mixture with solubilizer; permeability through skin
10/26/2010US7820196 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs
10/26/2010US7820195 Micronized device for the delivery of biologically active molecules and methods of use thereof
10/26/2010US7820193 Anticancer agents; prevent forming blood vessels; removal blockage
10/26/2010US7820192 controlling a sol-gel transition of polyethylene glycol (PEG)-containing hydrogels three-dimensional networks of crosslinked polymer chains by X-ray irradiation; for delivering a drug
10/26/2010US7820177 cosmetic or dermatological patch or pad comprises a polyacrylic acid polymer that forms a gel in water, water, a sea algae extract, and alcohol propanediol or/and glycerin; easy on skin
10/26/2010US7820171 administering to a ruminant animal with IgY antibodies isolated from eggs from hens immunized with a methanogen antigen; reducing methane gas evolved by the animal to reduce greenhouse gas emission; environmentally friendly
10/26/2010US7820158 Ligand-coupled initiator polymers and methods of use
10/26/2010US7820145 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions
10/26/2010US7819966 Surface-coated pearlescent pigments, process for preparing them, and their use
10/26/2010US7819908 Compositions and methods for reducing lung volume
10/26/2010US7819858 Remote controlled in vivo reaction method
10/26/2010US7819843 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
10/26/2010CA2661573C Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
10/26/2010CA2646756C Method of forming an aerosol for inhalation delivery
10/26/2010CA2581530C Composition in micro-pellets with controlled release of physiologically active substance, procedure for their preparation and use in the zoothechnical sector
10/26/2010CA2503831C Barriers for bioactive agent-containing polymeric coatings
10/26/2010CA2457780C Topical compositions and methods for treating pain
10/26/2010CA2454449C Synergistic filler composition of pvp-va and silicified mycrocrystalline cellulose for tablet dosage form
10/26/2010CA2440114C Organometallic framework materials and process for preparing them
10/26/2010CA2418921C Novel composition
10/26/2010CA2410201C Zoledronic acid or salts thereof for use in the treatment of conditions of abnormally increased bone turnover
10/26/2010CA2404641C Oral delivery method and composition for solid medications or dietary supplements
10/26/2010CA2381229C Stabilized g-csf preparations
10/26/2010CA2163111C Process for the preparation of an oral solid dosage form containing diclofenac
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010121024A2 Silicone-peroxide compositions for long-term, controlled oxygen release
10/21/2010WO2010120963A1 Tablet formulation for p38 inhibitor and method
10/21/2010WO2010120905A2 Novel nano-probes for molecular imaging and targeted therapy of diseases
10/21/2010WO2010120892A2 Improved oral drug devices and drug formulations
10/21/2010WO2010120841A1 Aqueous ophthalmic compositions containing anionic therapeutic agents
10/21/2010WO2010120817A2 Nanochanneled device and related methods
10/21/2010WO2010120781A1 Enzyme delivery systems and methods of preparations and use
10/21/2010WO2010120755A1 Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound
10/21/2010WO2010120662A2 Bioavailable compositions of amorphous alpha-(n-sulfonamido)acetamide compound
10/21/2010WO2010120489A2 Drug delivery system and methods of use
10/21/2010WO2010120389A2 Polymeric drug delivery systems and processes for producing such systems
10/21/2010WO2010120385A1 pH SENSITIVE BIODEGRADABLE POLYMERIC PARTICLES FOR DRUG DELIVERY
10/21/2010WO2010120332A1 Agents and methods to stimulate bone healing
10/21/2010WO2010120203A1 Use of organic dyes as analgesic agents
10/21/2010WO2010120172A1 Anti-reflux infant nutrition
10/21/2010WO2010119994A1 Polysaccharide derivative and hydrogel thereof
10/21/2010WO2010119942A1 Levocabastine suspension type eye lotion
10/21/2010WO2010119851A1 Orally disintegrating tablet
10/21/2010WO2010119741A1 Preparation for external use
10/21/2010WO2010119455A2 An injectable sustained release pharmaceutical composition
10/21/2010WO2010119387A2 A medicinal cream made using miconazole nitrate, fluticasone propionate, and chitosan, and a process to make the same
10/21/2010WO2010119385A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
10/21/2010WO2010119384A2 A medicinal cream made using mometasone furoate, and chitosan, and a process to make the same
10/21/2010WO2010119383A1 A medicinal cream made using framycetin sulphate cream and chitosan, and a process to make it
10/21/2010WO2010119369A2 A medicinal cream made using silver sulphadiazine and chitosan and a process to make it
10/21/2010WO2010119365A2 A medicinal cream made using clotrimazole and chitosan and a process to make the same
10/21/2010WO2010119319A1 Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
10/21/2010WO2010119305A1 Using of quaternary ammonium compounds in dissolving of latanoprost
10/21/2010WO2010119300A2 Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone
10/21/2010WO2010119132A1 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis and/or pruritus
10/21/2010WO2010119029A1 Method for on-demand contraception
10/21/2010WO2010119009A1 Tablets comprising a taste masking agent
10/21/2010WO2010118888A1 Formulation for stabilizing proteins, which is free of mammalian excipients
10/21/2010WO2010118683A1 Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof
10/21/2010WO2010118675A1 New use of neferine
10/21/2010WO2010118639A1 Amlodipine microsphere agent, production method and use thereof
1 ... 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 ... 2991